Significant Agreements - Narrative (Details) - USD ($) $ in Thousands |
1 Months Ended | |
|---|---|---|
Jul. 31, 2025 |
Jun. 30, 2025 |
|
| Juno Therapeutics, Inc. | Collaborative Arrangement, Research Collaboration and License Agreement | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Aggregate amount of the transaction price allocated to performance obligations that are partially unsatisfied | $ 67,900 | |
| Cystic Fibrosis Foundation | Collaborative Arrangement, Cystic Fibrosis Foundation Agreement | Subsequent Event | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Upfront payment | $ 24,000 | |
| Equity investment | $ 6,000 |